Literature DB >> 20971585

Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.

Mikkel Arendt1, Povl Munk-Jørgensen, Leo Sher, Signe O W Jensen.   

Abstract

This is a register-based cohort study of 20,581 individuals in treatment for illicit substance use disorders in Denmark between 1996 and 2006. All in all, 1441 deaths were recorded during 111,445 person-years of follow-up. Standardized mortality ratios (SMRs) associated with different primary substance types were calculated and Cox-regression analyses were performed in order to establish hazard ratios (HR) associated with injection drug use and psychiatric comorbidity. SMRs for primary users of specific substances were: cannabis: 4.9 (95% confidence interval (CI): 4.2-5.8), cocaine: 6.4 (CI: 3.9-10.0), amphetamine: 6.0 (CI: 4.2-8.3), heroin: 9.1 (CI: 8.5-9.8), and other opioids 7.7 (CI: 6.6-8.9). For MDMA ('ecstasy') the crude mortality rate was 1.7/1000 person-years (CI: 0.4-7.0) and the SMR was not significantly elevated. Injection drug use was associated with significantly increased hazard ratios in users of opioids and cocaine/amphetamine. Overall, psychiatric comorbidity was not associated with increased mortality (HR: 1.1 [CI: 0.9-1.2], p=.28), but an association was found specifically among cocaine/amphetamine users (HR: 3.6 [CI: 2.1-6.4], p<.001).
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971585     DOI: 10.1016/j.drugalcdep.2010.09.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  28 in total

1.  Estimation of the Number of People With Opioid Addiction in Germany.

Authors:  Ludwig Kraus; Nicki-Nils Seitz; Bernd Schulte; Peter Cremer-Schaeffer; Barbara Braun; Uwe Verthein; Tim Pfeiffer-Gerschel
Journal:  Dtsch Arztebl Int       Date:  2019-03-01       Impact factor: 5.594

2.  Marijuana use and health in primary care.

Authors:  Daniel Fuster; Jeffrey H Samet; Richard Saitz
Journal:  J Gen Intern Med       Date:  2014-02       Impact factor: 5.128

3.  Substance Use and Misuse: Emerging Epidemiological Trends, New Definitions, and Innovative Treatment Targets.

Authors:  Didier Jutras-Aswad
Journal:  Can J Psychiatry       Date:  2016-02-09       Impact factor: 4.356

4.  Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis.

Authors:  Emily Stockings; Lucy Thi Tran; Thomas Santo; Amy Peacock; Sarah Larney; Damian Santomauro; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2019-07-28       Impact factor: 6.526

5.  No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use.

Authors:  Daniel Fuster; Debbie M Cheng; Donald Allensworth-Davies; Tibor P Palfai; Jeffrey H Samet; Richard Saitz
Journal:  J Gen Intern Med       Date:  2013-09-19       Impact factor: 5.128

6.  Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert Lindblad; Lian Hu; Neal Oden; Paul Wakim; Carmen Rosa; Paul VanVeldhuisen
Journal:  J Subst Abuse Treat       Date:  2016-08-15

7.  Marijuana use and long-term mortality among survivors of acute myocardial infarction.

Authors:  Lauren Frost; Elizabeth Mostofsky; Joshua I Rosenbloom; Kenneth J Mukamal; Murray A Mittleman
Journal:  Am Heart J       Date:  2012-12-29       Impact factor: 4.749

8.  The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers.

Authors:  Theresa Winhusen; Jeff Theobald; David C Kaelber; Daniel Lewis
Journal:  Am J Drug Alcohol Abuse       Date:  2019-11-19       Impact factor: 3.829

Review 9.  The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.

Authors:  Christopher J Hammond
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-08-02

10.  Age, period and cohort trends in drug abuse hospitalizations within the total Swedish population (1975-2010).

Authors:  Giuseppe N Giordano; Henrik Ohlsson; Kenneth S Kendler; Marilyn A Winkleby; Kristina Sundquist; Jan Sundquist
Journal:  Drug Alcohol Depend       Date:  2013-11-19       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.